EMA Authorised: Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine;tenofovir disoproxil phosphate) — Zentiva k.s.

View source ↗

Summary

EMA authorised Emtricitabine/Tenofovir disoproxil Zentiva for HIV infections; a fixed-dose combination antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine; tenofovir disoproxil phosphate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Zentiva k.s.. Decision date: 18/03/2025